TrialTransplantation2013

A randomized pilot study of donor stem cell infusion in living-related kidney transplant recipients receiving alemtuzumab.

Gaetano Ciancio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.